BETHLEHEM, Pa.--(BUSINESS WIRE)--OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in oral fluid diagnostics, today announced quarterly revenues of $18.9 million for the three months ended June 30, 2008, compared to $21.4 million in revenues for the three months ended June 30, 2007. Increased sales of the Company’s OraQuick ADVANCE® rapid HIV-1/2 antibody test and insurance risk assessment products, as well as increased licensing and product development revenue during the second quarter 2008, were offset by expected decreased sales of the Company’s cryosurgical wart removal products and substance abuse testing products.
